Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis.
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review. JAMA Oncol. 2016 Jun 01; 2(6):805-12.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Humans
Mutation
Prognosis
Proto-Oncogene Proteins p21(ras)
authors with profiles
Thomas Hensing
Ravi Salgia